HLS Therapeutics Inc.
HLS
Rank in Stocks
#21943
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Share Price
$3.01
Last synced: 2026-10-19
Market Cap
$92.97M
Change (1 day)
0.86%
Change (1 year)
-25.24%
Country
CA
Trade HLS Therapeutics Inc. (HLS)
Category
Healthcare
Stock split history for HLS Therapeutics Inc. (HLS)
HLS Therapeutics Inc. stock (symbol: HLS) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One HLS share bought prior to Oct 20, 2026 would equal to 0 HLS shares today.
The most recent stock split occurred on Oct 20, 2026.
One HLS share bought prior to Oct 20, 2026 would equal to 0 HLS shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
